|
|
Article: Collaboration with the Institute of Cancer Research to Advance New Class of Anti-Cancer Agent into the Clinic.
- Article from:
- PR Newswire
- Article date:
- May 20, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SLOUGH, England, May 20 /PRNewswire/ --
- Collaborator Awarded US Research Grant by ABC2 to Test PIramed Drug Candidates in Brain Cancer
PIramed Limited (PIramed) today announced that it has entered into a research collaboration with The Institute of Cancer Research: Royal Cancer Hospital (The Institute) and Cancer Research Technology Limited to develop drugs targeting a critically important biochemical pathway in cancer cells. The research, to be conducted at PIramed and the Cancer Research UK Centre for Cancer Therapeutics at the Institute of Cancer Research in Sutton, Surrey, UK, will accelerate the progression of novel drug leads toward the clinic.
...